1. United States
2. La.
3. Letter

Dear [Representative/Senator’s Name], I am writing to express my strong support for the Patients Before Monopolies Act and to urge you to advocate for its swift passage. This bipartisan legislation addresses one of the most pressing issues in healthcare today: the monopolistic practices of pharmacy benefit managers (PBMs) that drive up drug prices, limit patient choice, and harm independent pharmacies. PBMs wield significant control over the pharmaceutical supply chain, often prioritizing their own profits at the expense of patients and communities. By owning both PBMs and pharmacy chains, large healthcare conglomerates have created an inherent conflict of interest, leading to inflated drug prices and reduced competition. The consequences are dire for patients who struggle to afford life-saving medications and for independent pharmacies that are being driven out of business. The Patients Before Monopolies Act is a much-needed step toward restoring fairness and competition in the healthcare market. Specifically, the Act would: 1. Prohibit healthcare companies from owning both PBMs and pharmacies, eliminating conflicts of interest. 2. Require divestment of any existing vertical integrations within three years. 3. Empower federal agencies like the FTC and the Department of Justice to enforce these rules and distribute disgorged revenues to communities harmed by these monopolistic practices. This legislation is not only a win for patients—it’s a win for the nation. By reducing drug prices and supporting independent pharmacies, the Act will improve access to affordable medications, foster competition, and strengthen local economies. I urge you to support this critical legislation and to advocate for its passage in Congress. Please let me know your stance on the Patients Before Monopolies Act and the actions you plan to take to advance this important bill. Thank you for your attention to this matter. I look forward to your response.